Headquarters
6255 PALO PINTO AVE, DALLAS, TX 75214-3617, US
DALLAS, TX, US
Immunoscope Inc.
From the company
ImmunoScope uses T cell receptor (TCR) analysis to enhance outcomes of bone marrow transplants. The company is developing the first predictive, pre-transplant TCR tests - the Novel and Tolerant Fraction tests - applying a proprietary algorithm and utilizing patient datasets with matched clinical outcomes data. Its mission is to provide transplant physicians with actionable intelligence improving transplant outcomes through more precise donor selection and treatment decisions.
Capabilities
Products & services
Where they operate
Location & facilities
Direct lines
Contact
Share quantities, requirements, and timing.
Send requirementsCompany record
Profile information
- Founded
- 2022
- Website
- immuno-scope.com
Source: company website
Start a conversation
Send your requirements
Quantities, certifications, delivery timing, and anything else needed to quote the work.